Transforming Growth Factor beta3: Clinical Trials

5 completed. 5 Phase 2, 2 Phase 1.

By phase and status

Phase	Trials	Status
Phase 2	5	Completed 5
Phase 1	2	Completed 2

Follow this drug Literature Review of Transforming Growth Factor beta3 trials Research Report on Transforming Growth Factor beta3

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Improvement in Scar Appearance Following Injection of Avotermin (Juvista) Into Skin Incisions Made in Healthy Men and Women Avotermin (Juvista), Placebo - Cicatrix	Phase 2	Completed	Renovo	78	2006-09-01	2008-03-06
Scar-Improvement Efficacy and Safety of a Single Intradermal Injection of Avotermin (Juvista) Administered Following Full-Thickness Skin Incisions Avotermin, Placebo - Cicatrix	Phase 2	Completed	Renovo	39	2006-07-01	2008-03-04
Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor Sites Avotermin, Placebo - Cicatrix, Wound Healing	Phase 2	Completed	Renovo	102	2003-10-01	2009-09-25
Genomic Changes Associated With the Use of Intradermal Avotermin (Juvista) in Small Wounds in Healthy Male Subjects Intradermal avotermin, Placebo (vehicle), Placebo - Cicatrix, Wound Healing	Phase 1 / Phase 2	Completed	Renovo	20	2002-09-01	2009-09-16
Investigation of the Safety, Dosing Frequency and Anti-Scarring Potential of Two Concentrations of Intradermal Avotermin (Juvista) Avotermin, Placebo - Cicatrix, Wound Healing	Phase 1 / Phase 2	Completed	Renovo	43	2002-02-01	2009-09-16

Conditions studied

Cicatrix (5)  ·  Arrhythmogenic Right Ventricular Dysplasia, Familial, 1 (1)

Sponsors

Renovo (5)

Countries

United Kingdom (5)

Top investigators

Jonathan Duncan (3)  ·  James Bush, MBChB (2)  ·  Michael J Davies (2)  ·  James Bush (1)  ·  Jeremy Bond (1)

Results publications

PMID 19362676